Healthcare Industry News:  TomoTherapy 

Devices Oncology

 News Release - January 23, 2008

TomoTherapy Releases Hi-Art(R) Treatment System Version 3.1

Update Expected to Increase Patient Throughput for Advanced Radiation Therapy

MADSION, Wis.--(HSMN NewsFeed)--TomoTherapy Incorporated (NASDAQ:TOMO ) announced today that it has begun shipping a faster version of its proven platform for image-guided, intensity-modulated radiation therapy (IG-IMRT). Version 3.1 of the TomoTherapy® Hi-Art® treatment system includes new software and hardware features that enhance clinical productivity and system usability, and are expected to increase patient throughput.

During December, TomoTherapy conducted a time-on-task study to assess the Hi-Art system version 3.1 enhancements in a clinical setting. Results show savings of up to 5 minutes per patient have been achieved over previous versions, based on a standard 20-minute treatment slot.

“We couldn’t be happier with the changes TomoTherapy has made,” said Dr. Lane Rosen, director of radiation oncology at the Shreveport, La.-based Willis-Knighton Cancer Center, a version 3.1 pilot site. “We were previously treating 20 to 25 patients a day with the Hi-Art system. Now, we can treat as many as 30 patients a day, with no compromise in the quality we’ve come to expect from this revolutionary technology.”

Said Fred Robertson, CEO of TomoTherapy: “We are very pleased to make Hi-Art 3.1 available to the radiation oncology community. This release demonstates that a cancer center doesn’t have to choose between reducing treatment times and delivering superior radiation therapy. The TomoTherapy Hi-Art treatment system empowers clinics to do both, with confidence.”

Software highlights of Hi-Art version 3.1 include a variety of delivery system design improvements that eliminate delays in the treatment process. Hardware updates include the addition of a second planning workstation to facilitate parallel clinical workflow, and the introduction of the new High Performance Couch, which provides efficiencies in the quality assurance, imaging and treatment processes.

All Hi-Art system orders shipped beginning Jan. 2, 2008 include the software and hardware features of version 3.1. Existing TomoTherapy customers will receive the software upgrade free of charge.

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, manufactures and sells the TomoTherapy® Hi-Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi-Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit www.TomoTherapy.com.

©2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi-Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.


Source: TomoTherapy

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.